Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.
Nathan Bryson, PhD
Advertisement
Articles by Nathan Bryson, PhD
Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?
Advertisement
Latest Updated Articles
RE104: A Novel, Fast-Acting Psychedelic for Postpartum DepressionPublished: June 26th 2024 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
2
Preliminary Report on Dangers of AI Chatbots
3
Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
